Press Release: Sanofi's Tzield approved in the US to delay the onset of stage 3 type 1 diabetes in young children
Go back to Press Release: Sanofi's Tzield approved in the US to delay the onset of stage 3 type 1 diabetes in young children| BANCO SANTANDER S.A. (NYSE: SAN) | Delayed: 13.61 -0.1 (0.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.71 | 52 Week High | $5.58 | |||
| Open | $13.51 | 52 Week Low | $3.60 | |||
| Day High | $13.62 | P/E | N/A | |||
| Day Low | $13.48 | EPS | $0.00 | |||
| Volume | 4,257,740 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 41.57 -0.21 (0.5%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $41.78 | 52 Week High | $44.76 | |||
| Open | $42.27 | 52 Week Low | $36.81 | |||
| Day High | $42.47 | P/E | N/A | |||
| Day Low | $41.56 | EPS | $0.00 | |||
| Volume | 6,868,390 | |||||
